[HTML][HTML] Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response
J Chen, S Chen, X Dai, L Ma, Y Chen, W Bian… - Frontiers in …, 2022 - frontiersin.org
Background Preclinical trials of immunotherapy in ovarian cancer (OC) have shown
promising results. This makes it meaningful to prospectively examine the biological …
promising results. This makes it meaningful to prospectively examine the biological …
Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response.
J Chen, S Chen, X Dai, L Ma, Y Chen… - Frontiers in …, 2022 - europepmc.org
Background Preclinical trials of immunotherapy in ovarian cancer (OC) have shown
promising results. This makes it meaningful to prospectively examine the biological …
promising results. This makes it meaningful to prospectively examine the biological …
Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response
J Chen, S Chen, X Dai, L Ma, Y Chen… - Community series in …, 2022 - books.google.com
Background: Preclinical trials of immunotherapy in ovarian cancer (OC) have shown
promising results. This makes it meaningful to prospectively examine the biological …
promising results. This makes it meaningful to prospectively examine the biological …
[HTML][HTML] Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response
J Chen, S Chen, X Dai, L Ma, Y Chen… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Background Preclinical trials of immunotherapy in ovarian cancer (OC) have shown
promising results. This makes it meaningful to prospectively examine the biological …
promising results. This makes it meaningful to prospectively examine the biological …
Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response
J Chen, S Chen, X Dai, L Ma, Y Chen… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Preclinical trials of immunotherapy in ovarian cancer (OC) have shown
promising results. This makes it meaningful to prospectively examine the biological …
promising results. This makes it meaningful to prospectively examine the biological …
Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response.
J Chen, S Chen, X Dai, L Ma, Y Chen… - Frontiers in …, 2022 - europepmc.org
Background Preclinical trials of immunotherapy in ovarian cancer (OC) have shown
promising results. This makes it meaningful to prospectively examine the biological …
promising results. This makes it meaningful to prospectively examine the biological …